Brainsway Ltd.

Medical technology company

BWAY Tel Aviv Stock Exchange · home listing Tel Aviv Stock Exchange BWAY Nasdaq ISIN IL0011007189 SEC CIK 1505065
Follow Brainsway Ltd. Weekly email: filings, results

Financials

Reported figures only · latest: Q2 2025 USD · IFRS
EPS, diluted -

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, IFRS
Revenue and net income9 fiscal years
  • Revenue
  • Net income
−$20M$0$20M$40M$60MFY16FY17FY18FY19FY20FY21FY22FY23FY24
Show the numbers
YearRevenueNet income
FY24$41M$2.9M
FY23$31.8M−$4.2M
FY22$27.2M−$13.3M
FY21$29.7M−$6.5M
FY20$22.1M−$5.4M
FY19$23.1M−$10.3M
FY18$16.4M−$6.5M
FY17$11.1M−$7.1M
FY16--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−100%−50%0%50%100%FY16FY17FY18FY19FY20FY21FY22FY23FY24
Show the numbers
YearGross marginOperating marginNet margin
FY2474.6%3.4%7.1%
FY2373.9%−15.6%−13.2%
FY2273.8%−46.7%−49.1%
FY2177.7%−16.9%−21.8%
FY2077.1%−21.9%−24.4%
FY1977.8%−36.7%−44.7%
FY1878.1%−31.2%−39.5%
FY1776.7%−59.3%−63.3%
FY16---
Free cash flowOperating cash flow minus capital expenditure
−$15M−$10M−$5M$0FY16FY17FY18FY19FY20FY21FY22FY23FY24
Show the numbers
YearFree cash flow
FY24-
FY23-
FY22-
FY21−$1.4M
FY20−$3.9M
FY19−$10.6M
FY18−$5.7M
FY17−$4.5M
FY16-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Brainsway Ltd.
  • Healthcare median
−100%−75%−50%−25%0%25%FY16FY17FY18FY19FY20FY21FY22FY23FY24
Show the numbers
YearBrainsway Ltd.Healthcare median
FY247.1%−47%
FY23−13.2%−58%
FY22−49.1%−80.4%
FY21−21.8%−71.9%
FY20−24.4%−62.2%
FY19−44.7%−46.3%
FY18−39.5%−49.6%
FY17−63.3%−45.9%
FY16-−36%